CaPP3 Central Study Team

The Newcastle based central study team

Standing (from left to right): Jackie Greenwood, Research Nurse;
Lynn Reed, Study Coordinator; Christine Hayes, Research Technician;
Donna Job, Project Assistant

Sitting (from left to right): Lynne Longstaff, Study Coordinator; Gemma Gills, Trial Manager, Gill Borthwick, Programme Manager

Find Out More

Latest News

12
Jan
2023
GPs unwilling to prescribe aspirin to people at risk of bowel cancer
posted on Thursday, 12th January 2023
Published on: 22 December 2022
Not tagged.
Comments (0)
27
Jul
2022
Starch supplement reduces the risk of some hereditary cancers - New Scientist
posted on Wednesday, 27th July 2022
Taking a supplement of 30 grams of 'resistant starch' a day - about the amount in two slightly unripe bananas - reduced the risk of multiple forms of cancer in people with a rare genetic condition - read more
Not tagged.
Comments (0)

Downloads

Cancer Prevention with Resistant Starch in Lynch Syndrome Patients in the CAPP2-Randomized Placebo Controlled Trial: Planned 10-Year Follow-up
posted on Monday, 8th August 2022
Guidelines for the management of hereditary colorectal cancer
posted on Tuesday, 26th July 2022

CaPP3 Central Study Team

Find Out More

Latest News

GPs unwilling to prescribe aspirin to people at risk of bowel cancer

Starch supplement reduces the risk of some hereditary cancers - New Scientist

Downloads

Cancer Prevention with Resistant Starch in Lynch Syndrome Patients in the CAPP2-Randomized Placebo Controlled Trial: Planned 10-Year Follow-up

Guidelines for the management of hereditary colorectal cancer

Contact Info

CaPP3 Study

In association with

Join Us

Donate